搜索临床试验以:Contraindications to standard therapies
总计475136个结果
-
University Health Network, TorontoDystonia Medical Research Foundation未知
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Eli Lilly and Company; Beth Israel Deaconess Medical Center; Brigham...完全的
-
Hadassah Medical Organization未知Female Patients Aged 5-35 Prior to Systemic Chemotherapy | With Significant Risk of Ovarian Toxicity以色列
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's Hospital完全的
-
Callisto Pharmaceuticals完全的
-
Fred Hutchinson Cancer CenterNational Institutes of Health (NIH); Burroughs Wellcome完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完全的
-
The University of Texas Health Science Center,...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic完全的
-
Vertex Pharmaceuticals Incorporated完全的
-
Eli Lilly and Company完全的癌,非小细胞肺癌荷兰, 西班牙, 美国, 加拿大, 以色列, 德国
-
Stanford UniversityMedtronic完全的
-
University of PittsburghSanofi完全的
-
University of WashingtonCenters for Disease Control and Prevention完全的
-
IKFE Institute for Clinical Research and Development完全的
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的